Takeda Presents Updated Results for Mobocertinib, Further Substantiating the Clinical Benefit in Patients with EGFR Exon20 Insertion+ mNSCLC
? Mobocertinib, an Oral Targeted Therapy, Demonstrated a Median Overall Survival of 24 Months, and…
? Mobocertinib, an Oral Targeted Therapy, Demonstrated a Median Overall Survival of 24 Months, and…
CALGARY, Alberta, May 19, 2021 (GLOBE NEWSWIRE) -- Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.DB,…
Donations to be Distributed through C.H. Robinson to Health Systems and Key Areas by Direct…
ATLANTA--(BUSINESS WIRE)--Green Atom Renewable Energy Corporation has awarded PIC Group the Operation and Maintenance Agreement…
DUBLIN--(BUSINESS WIRE)--The "Hong Kong Data Center Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021…
DUBLIN--(BUSINESS WIRE)--The "Global and Chinese Alginate Oligosaccharide Industry, 2021 Market Research Report" has been added…
DUBLIN--(BUSINESS WIRE)--The "Global and Chinese Third-Party Payment Industry, 2021 Market Research Report" report has been…
Derivatives portfolio management expert and former Goldman Sachs quant to support the increased footprint and…
The China National Intellectual Property Administration (CNIPA) has granted comprehensive protection for the composition and…
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Packaged Sunflower Seeds Market By Distribution Channel (Offline and Online), By…